J&J Profit Slips as Generic Rivals and Recalls Sap Sales

J&J Profit Slips as Generic Rivals and Recalls Sap Sales

Daniel Acker/Bloomberg

The company has also lost ground to rival makers of over-the-counter painkillers, after quality problems forced it to pull more than 40 brands of Tylenol and Motrin last year.